| 标题 |
Ifinatamab deruxtecan, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Johnson ML; Patel MR; Falchook GS; Koyama T; Gutierrez M; et al 出版日期:2026/04/01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)